Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144177 · ClinicalTrials.gov registry record · Phase 4
Induction in the Dark
A Phase 4 study of Anesthesia Induction, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06144177: Recruiting Phase 4 study of Anesthesia Induction, sponsored by Medical University of South Carolina.
NCT06144177 is a Phase 4 study of Anesthesia Induction that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 240 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06144177, a Phase 4 study of Anesthesia Induction, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll children ages 2-6 who are undergoing an elective outpatient surgical procedure under general anesthesia. They will be randomized to one of the following groups and assessed for preoperative anxiety, mask acceptance, and behavioral changes in the following week. 1. darkened room and star projector with parental presence; 2. preoperative midazolam 0.5 mg/kg by mouth and parental presence; or 3. parental presence alone.
Primary Outcome
Mask acceptance during inhalational mask induction as measured by the mask acceptance scale (MAS). The MAS is scored on a scale from 1-4 by evaluating if the child is calm and accepting of the mask (4), slightly scared but easily calmed (3), has moderate fear of the mask and is not easily calmed (2), or cries, screams, or is terrified (1) during induction when using the inhalation mask. A higher score is better.
Conditions Studied
Interventions
- OTHER Dark with star projector
- DRUG Preoperative midazolam
- OTHER Parental Presence
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2026-06-22 |
| Phase | Phase 4 |
What NCT06144177 shows while recruiting
NCT06144177 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Anesthesia Induction appearing as the primary indexed condition, and to 3 interventions - of which Dark with star projector is the first listed.
NCT06144177 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06144177 about?
NCT06144177 is a clinical study titled "Induction in the Dark". This study will enroll children ages 2-6 who are undergoing an elective outpatient surgical procedure under general anesthesia. They will be randomized to one of the following groups and assessed for preoperative anxiety, mask acceptance, and behavioral changes in the following week. 1. darkened ro...
What is the current status of trial NCT06144177?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2024-04-16. Estimated completion is 2026-06-22.
What conditions does trial NCT06144177 study?
This clinical trial studies the following conditions: Anesthesia Induction.
What interventions are being tested in trial NCT06144177?
The interventions under investigation include: Dark with star projector (OTHER), Preoperative midazolam (DRUG), Parental Presence (OTHER).
Who is sponsoring clinical trial NCT06144177?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06144177 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia Induction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06144177's enrollment target sits among peer trials
240 360th of 2000 higher than 1,636 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI